Tadashi Kosaka Selected Research

Tadashi Kosaka Research Topics

Disease

8	Hypersensitivity (Allergy) 07/2016 - 06/2009
6	Crohn Disease (Crohn's Disease) 04/2013 - 03/2002
5	Infections 04/2022 - 03/2004
5	Inflammation (Inflammations) 08/2014 - 05/2005
4	Hypertrophy 04/2024 - 01/2018
3	Lung Injury 07/2011 - 01/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2005 - 03/2002
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2023
2	Hyperplasia 10/2022 - 01/2018
2	Anemia 01/2018 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 04/2013 - 03/2010
2	Neoplasms (Cancer) 01/2012 - 01/2010
2	Pneumonia (Pneumonitis) 11/2010 - 04/2007
2	Atrophy 03/2010 - 10/2002
2	Ulcerative Colitis 10/2007 - 03/2002
1	Cholangitis 10/2023
1	Fever (Fevers) 01/2023
1	Chills 01/2023
1	Bacteremia 04/2022
1	Candidemia 01/2020
1	Sepsis (Septicemia) 11/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Cross Infection (Nosocomial Infection) 02/2016
1	Body Weight (Weight, Body) 04/2013
1	Communicable Diseases (Infectious Diseases) 04/2013
1	Carcinogenesis 04/2013
1	Fibrosis (Cirrhosis) 11/2010
1	Lung Diseases (Lung Disease) 11/2010
1	Respiratory Hypersensitivity 05/2010

Drug/Important Bio-Agent (IBA)

4	trimellitic anhydrideIBA 07/2016 - 06/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 03/2004
3	CytokinesIBA 07/2016 - 11/2002
3	AllergensIBA 08/2014 - 05/2010
3	OrganophosphatesIBA 08/2014 - 07/2009
3	GlycopeptidesIBA 04/2013 - 10/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2013 - 01/2010
2	Hormones (Hormone)IBA 04/2024 - 10/2022
2	Monoclonal AntibodiesIBA 01/2023 - 01/2023
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2023
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2023 - 01/2018
2	Methoxychlor (Metox)IBA 08/2014 - 10/2002
2	Chlorinated HydrocarbonsIBA 08/2014 - 06/2011
2	IronIBA 01/2013 - 10/2009
2	didecyldimethylammonium (didecyldimethylammonium chloride)IBA 07/2011 - 11/2010
2	Dinitrochlorobenzene (DNCB)IBA 06/2011 - 05/2010
2	Immunoglobulin E (IgE)IBA 05/2010 - 04/2007
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2023
1	Cefmetazole (Cefmetazole Sodium)FDA Link 10/2023
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 10/2023
1	chromated copper arsenateIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2023
1	pertuzumabIBA 01/2023
1	Virulence Factors (Pathogenicity Factors)IBA 04/2022
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2022
1	LipidsIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Theophylline (Theon)FDA LinkGeneric 01/2018
1	Caffeine (No Doz)FDA LinkGeneric 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	LipofuscinIBA 01/2018
1	Anti-Infective Agents (Microbicides)IBA 02/2016
1	QuinolonesIBA 02/2016
1	Piperonyl Butoxide FDA Link 08/2014
1	InsecticidesIBA 08/2014
1	OvalbuminIBA 08/2014
1	Parathion (Ethyl Parathion)IBA 08/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2014
1	Glutaral (Glutaraldehyde)IBA 01/2014
1	CreatinineIBA 04/2013
1	Vancomycin FDA LinkGeneric 04/2013
1	XenobioticsIBA 04/2013
1	TeicoplaninIBA 04/2013
1	Budesonide (Pulmicort)FDA LinkGeneric 04/2013
1	LipopolysaccharidesIBA 01/2013
1	DDTIBA 01/2013
1	Methotrexate (Mexate)FDA LinkGeneric 01/2012
1	Procollagen Type IIBA 11/2010
1	N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)IBA 11/2010
1	CC ChemokinesIBA 11/2010
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 11/2010
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2010
1	Local Anti-Infective Agents (Antiseptics)IBA 11/2010
1	Messenger RNA (mRNA)IBA 11/2010
1	Surface Antigens (Surface Antigen)IBA 05/2010
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 05/2010
1	Immunoglobulin G (IgG)IBA 05/2010
1	Irritants (Vesicants)IBA 05/2010
1	phthalic anhydrideIBA 05/2010
1	ChemokinesIBA 05/2010
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 05/2010
1	AutoantigensIBA 03/2010
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2010

Therapy/Procedure

9	Therapeutics 10/2023 - 03/2002
2	Aftercare (After-Treatment) 11/2010 - 03/2004
2	Oral Administration 10/2009 - 04/2009
2	Enteral Nutrition (Feeding, Tube) 07/2004 - 01/2004
1	Central Venous Catheters 01/2020